Literature DB >> 12091473

Alterations in metabolism and gene expression in brain regions during cuprizone-induced demyelination and remyelination.

Helga Jurevics1, Carrie Largent, Janell Hostettler, Deanne W Sammond, Glenn K Matsushima, Amber Kleindienst, Arrel D Toews, Pierre Morell.   

Abstract

Exposure of mice to the copper chelator, cuprizone, results in CNS demyelination. There is remyelination after removal of the metabolic insult. We present brain regional studies identifying corpus callosum as particularly severely affected; 65% of cerebroside is lost after 6 weeks of exposure. We examined recovery of cerebroside and ability to synthesize cerebroside and cholesterol following removal of the toxicant. The temporal pattern for concentration of myelin basic protein resembled that of cerebroside. We applied Affymetrix GeneChip technology to corpus callosum to identify temporal changes in levels of mRNAs during demyelination and remyelination. Genes coding for myelin structural components were greatly down-regulated during demyelination and up-regulated during remyelination. Genes related to microglia/macrophages appeared in a time-course (peaking at 6 weeks) correlating with phagocytosis of myelin and repair of lesions. mRNAs coding for many cytokines had peak expression at 4 weeks, compatible with intercellular signaling roles. Of interest were other genes with temporal patterns correlating with one of the three above patterns, but of function not obviously related to demyelination/remyelination. The ability to correlate gene expression with known pathophysiological events should help in elucidating further function of such genes as related to demyelination/remyelination.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12091473     DOI: 10.1046/j.1471-4159.2002.00954.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  42 in total

Review 1.  The role of TAM family receptors and ligands in the nervous system: From development to pathobiology.

Authors:  Bridget Shafit-Zagardo; Ross C Gruber; Juwen C DuBois
Journal:  Pharmacol Ther       Date:  2018-03-04       Impact factor: 12.310

2.  CXCR2-positive neutrophils are essential for cuprizone-induced demyelination: relevance to multiple sclerosis.

Authors:  LiPing Liu; Abdelmadjid Belkadi; Lindsey Darnall; Taofang Hu; Caitlin Drescher; Anne C Cotleur; Dolly Padovani-Claudio; Tao He; Karen Choi; Thomas E Lane; Robert H Miller; Richard M Ransohoff
Journal:  Nat Neurosci       Date:  2010-02-14       Impact factor: 24.884

3.  Therapeutic inhibition of soluble brain TNF promotes remyelination by increasing myelin phagocytosis by microglia.

Authors:  Maria Karamita; Christopher Barnum; Wiebke Möbius; Malú G Tansey; David E Szymkowski; Hans Lassmann; Lesley Probert
Journal:  JCI Insight       Date:  2017-04-20

4.  Suppressor of cytokine signaling 3 limits protection of leukemia inhibitory factor receptor signaling against central demyelination.

Authors:  Ben Emery; Holly S Cate; Mark Marriott; Tobias Merson; Michele D Binder; Cameron Snell; Pik Ying Soo; Simon Murray; Ben Croker; Jian-Guo Zhang; Warren S Alexander; Helen Cooper; Helmut Butzkueven; Trevor J Kilpatrick
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-08       Impact factor: 11.205

5.  Combination of growth factors enhances remyelination in a cuprizone-induced demyelination mouse model.

Authors:  Shalini Kumar; Juan Carlos Biancotti; Masahiro Yamaguchi; Jean de Vellis
Journal:  Neurochem Res       Date:  2006-12-21       Impact factor: 3.996

6.  Proteomic analysis of demyelinated and remyelinating brain tissue following dietary cuprizone administration.

Authors:  Sean R Werner; Joy K Saha; Carol L Broderick; Eugene Y Zhen; Richard E Higgs; Kevin L Duffin; Rosamund C Smith
Journal:  J Mol Neurosci       Date:  2010-04-17       Impact factor: 3.444

7.  AAV-mediated gene delivery in adult GM1-gangliosidosis mice corrects lysosomal storage in CNS and improves survival.

Authors:  Rena C Baek; Marike L D Broekman; Stanley G Leroy; Laryssa A Tierney; Michael A Sandberg; Alessandra d'Azzo; Thomas N Seyfried; Miguel Sena-Esteves
Journal:  PLoS One       Date:  2010-10-18       Impact factor: 3.240

8.  Comparative prion disease gene expression profiling using the prion disease mimetic, cuprizone.

Authors:  Laura R Moody; Allen J Herbst; Han Sang Yoo; Joshua P Vanderloo; Judd M Aiken
Journal:  Prion       Date:  2009-04-19       Impact factor: 3.931

9.  Statin therapy inhibits remyelination in the central nervous system.

Authors:  Veronique E Miron; Simone P Zehntner; Tanja Kuhlmann; Samuel K Ludwin; Trevor Owens; Timothy E Kennedy; Barry J Bedell; Jack P Antel
Journal:  Am J Pathol       Date:  2009-04-06       Impact factor: 4.307

10.  Age-related and cuprizone-induced changes in myelin and transcription factor gene expression and in oligodendrocyte cell densities in the rostral corpus callosum of mice.

Authors:  J Ronald Doucette; Rubin Jiao; Adil J Nazarali
Journal:  Cell Mol Neurobiol       Date:  2010-01-09       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.